Follow
Suzanne Hagan
Suzanne Hagan
Dr
Verified email at gcu.ac.uk
Title
Cited by
Cited by
Year
MAP kinase signalling pathways in cancer
AS Dhillon, S Hagan, O Rath, W Kolch
Oncogene 26 (22), 3279-3290, 2007
36012007
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis
S Hagan, F Al-Mulla, E Mallon, K Oien, R Ferrier, B Gusterson, ...
Clinical Cancer Research 11 (20), 7392-7397, 2005
3402005
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
ESA Hagan S, Martin E
EPMA J 7, 15, 2016
325*2016
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines
MM Schuierer, F Bataille, S Hagan, W Kolch, AK Bosserhoff
Cancer research 64 (15), 5186-5192, 2004
2592004
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome
HCT Groom, VC Boucherit, K Makinson, E Randal, S Baptista, S Hagan, ...
Retrovirology 7, 1-10, 2010
2472010
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
F Al-Mulla, S Hagan, AI Behbehani, MS Bitar, SS George, JJ Going, ...
Journal of Clinical Oncology 24 (36), 5672-5679, 2006
2142006
Hepatocyte growth factor/scatter factor in the eye
I Grierson, L Heathcote, P Hiscott, P Hogg, M Briggs, S Hagan
Progress in retinal and eye research 19 (6), 779-802, 2000
1632000
EPMA position paper in cancer: current overview and future perspectives
G Grech, X Zhan, BC Yoo, R Bubnov, S Hagan, R Danesi, G Vittadini, ...
EPMA Journal 6, 1-31, 2015
1142015
Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability
F Al-Mulla, S Hagan, W Al-Ali, SP Jacob, AI Behbehani, MS Bitar, A Dallol, ...
Journal of clinical pathology 61 (4), 524-529, 2008
1052008
Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC)
P Hiscott, S Hagan, L Heathcote, CM Sheridan, CP Groenewald, ...
Eye 16 (4), 393-403, 2002
1012002
Targeted therapies in colorectal cancer—an integrative view by PPPM
S Hagan, MCM Orr, B Doyle
EPMA Journal 4, 1-16, 2013
862013
A gene signature for post-infectious chronic fatigue syndrome
JW Gow, S Hagan, P Herzyk, C Cannon, PO Behan, A Chaudhuri
BMC medical genomics 2, 1-11, 2009
852009
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma
AGM Scholes, T Liloglou, P Maloney, S Hagan, J Nunn, P Hiscott, ...
Investigative ophthalmology & visual science 42 (11), 2472-2477, 2001
652001
Tear fluid biomarker profiling: a review of multiplex bead analysis
S Hagan, A Tomlinson
The ocular surface 11 (4), 219-235, 2013
622013
Raf kinase inhibitor protein regulation of raf and MAPK signaling
S Hagan, R Garcia, A Dhillon, W Kolch
Methods in enzymology 407, 248-259, 2006
572006
Cultured human retinal pigment epithelial cells differentially express thrombospondin-1,-2,-3, and-4
JA Carron, P Hiscott, S Hagan, CM Sheridan, R Magee, JA Gallagher
The international journal of biochemistry & cell biology 32 (11-12), 1137-1142, 2000
462000
Biomarkers of ocular surface disease using impression cytology
S Hagan
Biomarkers in medicine 11 (12), 1135-1147, 2017
392017
Patient-reported severity of dry eye and quality of life in diabetes
MK Yazdani-ibn-Taz, MM Han, S Jonuscheit, A Collier, JE Nally, S Hagan
Clinical Ophthalmology (Auckland, NZ) 13, 217, 2019
382019
Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma
AGM Scholes, S Hagan, P Hiscott, BE Damato, I Grierson
Archives of ophthalmology 119 (3), 373-377, 2001
382001
Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis
CE Patek, MJ Arends, WAH Wallace, F Luo, S Hagan, DG Brownstein, ...
Experimental cell research 314 (5), 1105-1114, 2008
362008
The system can't perform the operation now. Try again later.
Articles 1–20